Daicel Arbor Biosciences
Private Company
Funding information not available
Overview
Daicel Arbor Biosciences, founded in 2005 and based in Ann Arbor, Michigan, is a specialized provider of research tools and services in the genomics and proteomics space. The company operates on a hybrid business model, offering both customizable products—such as its myBaits hybridization capture kits and myTXTL cell-free expression kits—and fee-for-service laboratory and bioinformatics support. As a subsidiary of the Japanese chemical company Daicel Corporation, it leverages this backing to serve a diverse academic and industrial research market, focusing on enabling complex applications like long-read sequencing, methylation analysis, and synthetic biology.
Technology Platform
Three core platforms: 1) myBaits for targeted NGS via hybridization capture, 2) myTags for cytogenetics FISH probes, and 3) myTXTL for cell-free protein expression. Supported by integrated sequencing and bioinformatics services.
Opportunities
Risk Factors
Competitive Landscape
Daicel Arbor competes in niche segments against giants like Illumina and Thermo Fisher in NGS capture, and against specialized firms like Twist Bioscience in targeted panels. In cell-free expression, it competes with companies like Arbor Biosciences (the original entity) and other synthetic biology tool providers. Its differentiation lies in customizability, application expertise, and integrated service support.